2014 | Medical Innovation Summit

Now, it's Personal

Cancer Treatment and Personalized Medicine October 27-29, 2014 Cleveland, Ohio

  • Download Our FREE Mobile App

    Stay connected. Download today!

  • 2014 Summit Preview

    Join more than 1,500 senior executives, investors, entrepreneurs and clinicians who will gather in Cleveland to discuss investable innovations that can lead to the detection and treatment of cancer. The 2014 Summit will include:

    • Detailed insights into the latest breakthroughs of personalized medicine
    • Discussions with world leaders responsible for the change in healthcare technology.
    • Top 10 Medical Innovations for 2015
  • Sponsor Innovation

    Why Sponsor the Medical Innovation Summit?

    • Access over 1,500 healthcare decision makers
    • Lead the conversation when it comes to innovation in healthcare
    • Partner with us to initiate collaborative ideas for advancing healthcare.
    Contact Us Today!
  • Do You Have What IT Takes?

    Cleveland Clinic and the Summit are searching the globe for the next early stage Health IT companies that will disrupt the market and streamline the delivery of better care to patients everwhere. Submmissions are due by May 30.

    Apply Today!

Featured Speakers

| View All Speakers

Jeffrey R. Immelt

Chairman and CEO


Jeffrey R. Immelt | Chairman and CEO ,

Jeffrey R. Immelt is the ninth chairman of GE, a post he has held since September 7, 2001. Mr. Immelt has held several global leadership positions since coming to GE in 1982, including roles in GE's Plastics, Appliances, and Healthcare businesses. In 1989 he became an officer of GE and joined the GE Capital Board in 1997. A couple years later, in 2000, Mr. Immelt was appointed president and chief executive officer.

Mr. Immelt has been named one of the "World's Best CEOs" three times by Barron's, and since he began serving as chief executive officer, GE has been named "America's Most Admired Company" in a poll conducted by Fortune magazine and one of "The World's Most Respected Companies" in polls by Barron's and the Financial Times.

Mr. Immelt was the chair of President Obama's Council on Jobs and Competitiveness. He is a member of The American Academy of Arts & Sciences.

Mr. Immelt earned a B.A. degree in applied mathematics from Dartmouth College in 1978 and an M.B.A. from Harvard University in 1982. He and his wife have one daughter.

Elaine Jones, PhD

Executive Director

Pfizer Ventures

Elaine Jones, PhD | Executive Director ,

Elaine V. Jones, PhD joined Pfizer Venture Investments as Executive Director, Venture Capital in 2008.  She is responsible for making and managing venture investments for Pfizer and currently manages the PVI investments in Aquinox Pharmaceuticals (Vancouver, B.C.), Autifony Therapeutics Ltd. (London, UK), Flexion Therapeutics (Boston, MA), Mersana Therapeutics (Cambridge, MA), Merus B.V. (Utrecht, The Netherlands), MIRNA Therapeutics (Austin, TX), Mission Therapeutics (Cambridge, UK), Neuronetics Inc. (Malvern, PA) and TetraLogic Pharma (Malvern, PA).  Elaine brings 13 years of venture capital experience and a strong background in research and product assessment, built on her significant experience in pharmaceutical drug discovery and business development to the PVI team. 

Most recently, Elaine was a General Partner with the venture fund, EuclidSR Partners.  There, she was responsible for the fund’s investments in Acurian, Fluidigm, InnaPhase and Targacept. 

Prior to joining ESR, Dr. Jones began her private equity career in 1999 at S.R. One, GlaxoSmithKline’s venture fund, where she managed investments including Adolor, Avantium, Nucleonics, Scynexis and Vicuron.  Previously, she served as Director of Scientific Licensing for SmithKline Beecham and was a research scientist in SmithKline Beecham Pharmaceutical R&D. 

Dr. Jones is a graduate of Juniata College and received her PhD in Microbiology from the University of Pittsburgh.

Lee Newcomer, MD

Senior Vice President, Oncology, Genetics & Women's Health

UnitedHealthcare Group

Lee Newcomer, MD | Senior Vice President, Oncology, Genetics & Women's Health ,

Lee N. Newcomer, MD, MHA, is the Senior Vice President at UnitedHealthcare (UHC) with strategic responsibility for Oncology, Genetics and Women’s Health. 

He began his management career as a Medical Director for CIGNA Health Care of Kansas City in 1990.  From 1991 to 2000, Dr. Newcomer was the Chief Medical Officer at UHC where his work emphasized the development of performance measures and incentives to improve clinical care.  Dr. Newcomer was a founding executive of Vivius, a consumer directed venture that allowed consumers to create their own personalized health plans.  He returned to UHC in 2006 to focus on combining clinical, financial and administrative incentives for improved and affordable cancer care.

Dr. Newcomer is a board certified medical oncologist; he practiced medical oncology for nine years in Tulsa, Oklahoma and Minneapolis (Park Nicollet Clinic).   

He is the former Chairman of Park Nicollet Health Services (now HealthPartners), an integrated system of physicians and hospitals in the Minneapolis and St Paul metropolitan area.  The group is nationally recognized for its leadership in quality, safety and cost effectiveness.

Dr. Newcomer earned a BA degree from Nebraska Wesleyan University, an MD degree from the University of Nebraska College of Medicine, and a Masters of Health Administration from the University of Wisconsin at Madison. He completed his internship and residency in internal medicine at the University of Nebraska Medical Center and a fellowship in medical oncology at the Yale University School of Medicine.

Why Attend?

The Medical Innovation Summit provides an unrivaled perspective on the newest medical innovations and the financial drivers behind those innovations. The conference is recognized for providing singular insights, networking opportunities and actionable take away for all participants. The content is designed for:

  • Senior executives in the healthcare industry
  • Clinical, medical affairs, regulatory and business development executives
  • Venture capitalists and angel investor groups
  • Investment bankers
  • Buy-side and sell-side researchers
  • Consulting, legal and other service providers

Agenda Highlights

Monday | October 27th
  • New Ventures Healthcare Challenge
  • The State of Healthcare Innovation
  • Dinner and Keynote Address
Tuesday | October 28th
  • You're Well Now, Are You Going to Get Sick?
  • You Have Cancer, Now What?
  • Imaging and Health IT
  • Networking Recepton
Wednesday | October 29th
  • The Next Generation of Drug Development
  • Radiation
  • Revealing of the Top 10 Medical Innovations for 2015

2013 Sponsors

View All Past Sponsors